<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="686">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>6/10/2005</approvaldate>
  <actrnumber>ACTRN12605000609651</actrnumber>
  <trial_identification>
    <studytitle>Effectiveness of training somatosensation in the hand after stroke: A randomized controlled trial.</studytitle>
    <scientifictitle>Effectiveness of training somatosensation in the hand after stroke: A randomized controlled trial.</scientifictitle>
    <utrn />
    <trialacronym>SENSe</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The experimental intervention (EI) will comprise 10 sessions of generalized discrimination training of texture discrimination, limb position sense and tactual object recognition. 
Sessions are 60-90 minutes duration and are conducted 3 times per week. Group A will receive two phases of EI. Group B will receive one phase of CI followed by one phase of EI.</interventions>
    <comparator>The control intervention (CI) will comprise 10 sessions of exposure to sensory stimuli.</comparator>
    <control>Placebo</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A multi-scale score of sensory discrimination performance based on improvement in the discrimination of functionally relevant sensory stimuli, i.e. texture discrimination, limb position sense and tactual object recognition.</outcome>
      <timepoint>Outcome assessments will be conducted at baseline, just prior to the commencement of the initial phase, and at the end of phase two.  Follow-up assessments will be conducted at 6 weeks and 6 months post training to determine maintenance of training effects.  Between-group comparison of intervention effect will be conducted at the end of phase one.  Within-group comparison of intervention effect will compare change during EI with preceding change during CI.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Hand function in self-care activities (measured using the Sequential Occupational Dexterity Assessment).</outcome>
      <timepoint>Outcome assessments will be conducted at baseline, just prior to the commencement of the initial phase, and at the end of phase two.  Follow-up assessments will be conducted at 6 weeks and 6 months post training to determine maintenance of training effects.  Between-group comparison of intervention effect will be conducted at the end of phase one.  Within-group comparison of intervention effect will compare change during EI with preceding change during CI.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Actual use of the upper limb in life situations will be measured using the Upper Extremity Motor Activity Log (UE/MAL).</outcome>
      <timepoint>These measures will be administered at the same time points as for the primary outcome measures.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The Barthel Index (BI) will also be employed as a secondary measure to provide a more global disability measure of performance in daily self-care activities.</outcome>
      <timepoint>These measures will be administered at the same time points as for the primary outcome measures.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria />
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Centralised randomisation with the person assigning the subjects different to the executor of the assignment. Allocation is communicated via sealed, opaque envelopes and/or confidential email.</concealment>
    <sequence>Sequence generation using computer random number generator with matching constraints.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Other</assignment>
    <designfeatures>Group A: E1, E1 and Group B: C1, E1</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>3/01/2002</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>LaTrobe University</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other</sponsortype>
      <sponsorname>National Stroke Research Institute</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>LaTrobe University</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Melbourne Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Southern Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Northern Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Barwon Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Donvale Rehabilitation Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Leeanne Carey</name>
      <address>National Stroke Research Institute
Austin Health
Repatriation Campus
Neurosciences Building
300 Waterdale Road
Heidelberg Heights VIC 3081</address>
      <phone>+61 3 94962586</phone>
      <fax>+61 3 94962650</fax>
      <email>lcarey@nsri.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Leeanne Carey</name>
      <address>National Stroke Research Institute
Austin Health
Repatriation Campus
Neurosciences Building
300 Waterdale Road
Heidelberg Heights VIC 3081</address>
      <phone>+61 3 94962586</phone>
      <fax>+61 3 94962650</fax>
      <email>lcarey@nsri.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>